Literature DB >> 23506707

Prohibitin and its rapidly emerging role as a biomarker of systemic malignancies.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23506707     DOI： 10.1016/j.humpath.2012.12.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  3 in total

1.  Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

Authors:  Yingjie Xu; Wen Yang; Jinjun Shi; Bruce R Zetter
Journal:  J Mol Cell Biol       Date:  2016-03-29       Impact factor: 6.216

2.  Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.

Authors:  Xiaoding Xu; Jun Wu; Yanlan Liu; Phei Er Saw; Wei Tao; Mikyung Yu; Harshal Zope; Michelle Si; Amanda Victorious; Jonathan Rasmussen; Dana Ayyash; Omid C Farokhzad; Jinjun Shi
Journal:  ACS Nano       Date:  2017-03-03       Impact factor: 15.881

3.  Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.

Authors:  Xi Zhu; Yingjie Xu; Luisa M Solis; Wei Tao; Liangzhe Wang; Carmen Behrens; Xiaoyang Xu; Lili Zhao; Danny Liu; Jun Wu; Ning Zhang; Ignacio I Wistuba; Omid C Farokhzad; Bruce R Zetter; Jinjun Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.